 Mitochondria as one of potential anticancer target alternatively damaging mtDNA other than nDNA is a potential method for platinum based anticancer drugs to overcome cisplatin resistance . We herein report that bromocoumarinplatin

@highlight Bromocoumarinplatin
@highlight demonstrated enhanced cytotoxic properties to cancer cells and high safety index to normal cells
@highlight and
@highlight could target simultaneously mitochondria and nuclei with the contents of Pt in nDNA and mtDNA were 25.75 and 65.91 respectively.
@highlight promoted the expression of p53 gene and protein more effectively than cisplatin leading to the increased anticancer activity of
@highlight The higher therapeutic indices of
@highlight for HCT 116 cells
@highlight indicated a vital function in the treatment of colon cancer.
